Collegium Pharmaceutical SG&A Expense (Quarterly) Analysis

Collegium Pharmaceutical Inc (COLL)

32.44 -1.23 (-3.65%) USD | NASDAQ | May 17, 16:00

32.44 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	41.98M
December 31, 2023	32.94M
September 30, 2023	35.30M
June 30, 2023	38.19M
March 31, 2023	52.78M
December 31, 2022	38.03M
September 30, 2022	38.37M
June 30, 2022	41.25M
March 31, 2022	54.53M
December 31, 2021	26.60M
September 30, 2021	30.51M
June 30, 2021	30.37M
March 31, 2021	31.48M
December 31, 2020	26.82M
September 30, 2020	26.43M
June 30, 2020	29.32M
March 31, 2020	31.26M
December 31, 2019	25.09M
September 30, 2019	30.07M
June 30, 2019	28.94M
March 31, 2019	32.35M

Date	Value
December 31, 2018	30.45M
September 30, 2018	33.45M
June 30, 2018	31.28M
March 31, 2018	31.58M
December 31, 2017	25.09M
September 30, 2017	22.76M
June 30, 2017	22.06M
March 31, 2017	22.85M
December 31, 2016	25.37M
September 30, 2016	23.57M
June 30, 2016	20.17M
March 31, 2016	11.52M
December 31, 2015	7.905M
September 30, 2015	5.907M
June 30, 2015	2.934M
March 31, 2015	2.185M
December 31, 2014	1.02M
September 30, 2014	0.687M
June 30, 2014	0.523M
March 31, 2014	0.475M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

25.09M

Minimum

Dec 2019

54.53M

Maximum

Mar 2022

34.51M

Average

31.37M

Median

SG&A Expense (Quarterly) Benchmarks